NDAORALCAPSULE
Approved
Feb 1970
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Mechanism of Action
Mechanism of Action Clindamycin inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome. Clindamycin is bacteriostatic.
Indications (10)
the treatment of serious infections caused by susceptible anaerobic bacteriathe treatment of serious infections due to susceptible strains of streptococcipneumococcistaphylococcidevelopment of drug-resistant bacteriamaintain the effectiveness of CLEOCIN HClother antibacterial drugsCLEOCIN HCl should be used only to treatprevent infectionsstrongly suspected to be caused by susceptible bacteria
Clinical Trials (1)
Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne
Started Mar 2015
245 enrolled
Acne